Rumors have swirled in Washington that Woodcock, a 35-year veteran of the FDA, would retire from the federal government.
WASHINGTON — Robert Califf, President Biden’s pick to lead the Food and Drug Administration, has asked Janet Woodcock, who has served as the FDA’s acting commissioner for the last 11 months, to stay on in a leadership role at the agency should he be confirmed by the Senate, two sources with knowledge of the discussion confirmed to STAT.
It’s still not clear exactly what Woodcock’s role would be or how she would split responsibilities with Califf, should she accept his offer. The most obvious role would be principal deputy commissioner, a position that amounts to second-in-charge at the agency and has been vacant since Amy Abernethy left it in April.
Rumors have swirled in Washington that Woodcock, a 35-year veteran of the FDA, would retire from the federal government after not being chosen to lead the agency. She gave up her longtime role as head of the FDA’s largest center, the Center for Drug Evaluation and Research, in April when she appointed her former deputy, Patrizia Cavazzoni, to that role.
IMHO, he needs her because the FDA has done so many unlawful things since the pandemic onset, and he will inherit plenty of coverup and cleaning up to do. For example, he will have to fight the Aaron Siri lawsuit (and possible Congressional bill) to try and delay the release of Pfizer’s vaccine package that the law says should already be available, over 55 years. He desperately needs Janet Woodcock; who else is as sly, and knows how to work the rules as well?